Little is known about the long-term course of disability in relation with disease severity in people with multiple sclerosis (PwMS).
To explore changes in a broad spectrum of disability over 10 years in relation with disease severity in PwMS.
We conducted a longitudinal study of 155 PwMS who attended the MS Centre at Karolinska University Hospital, Stockholm. Disease severity was determined by the use of the Expanded Disability Status Scale (EDSS) and classified as mild MS (EDSS score 0–3.5) or moderate/severe MS (EDSS score 4–9.5). Ten-year changes in perceived physical and psychological impacts of MS, walking, cognition, manual dexterity, participation in social/lifestyle activities, and signs of depression were compared between PwMS with mild and moderate/severe MS at baseline.
Although walking, manual dexterity, and cognition declined in both groups, only the moderate/severe group demonstrated that long-term increased physical impact of MS, increased wheel-chair dependency, and reduced participation in social/lifestyle activities. Perceived psychological impact of MS declined in both groups, while signs of depression were experienced by fewer in the mild group and remained unaltered in the moderate/severe group.
We found a more pronounced increase in disability across 10 years in individuals with moderate/severe MS compared to mild MS. These findings accentuate the importance of developing a variety of interventions that can be applied across the spectrum of disease severity.
Pugliatti M, Rosati G, Carton H, Riise T, Drulovic J, Vecsei L, Milanov I (2006) The epidemiology of multiple sclerosis in Europe. Eur J Neurol 13(7):700–722. https://doi.org/10.1111/j.1468-1331.2006.01342.x CrossRefPubMed
Tepavcevic DK, Pekmezovic T, Stojsavljevic N, Kostic J, Basuroski ID, Mesaros S, Drulovic J (2014) Change in quality of life and predictors of change among patients with multiple sclerosis: a prospective cohort study. Qual Life Res 23(3):1027–1037. https://doi.org/10.1007/s11136-013-0535-1 CrossRefPubMed
Chruzander C, Johansson S, Gottberg K, Einarsson U, Fredrikson S, Holmqvist LW, Ytterberg C (2013) A 10-year follow-up of a population-based study of people with multiple sclerosis in Stockholm, Sweden: changes in disability and the value of different factors in predicting disability and mortality. J Neurol Sci 332(1–2):121–127. https://doi.org/10.1016/j.jns.2013.07.003 CrossRefPubMed
Solari A, Ferrari G, Radice D (2006) A longitudinal survey of self-assessed health trends in a community cohort of people with multiple sclerosis and their significant others. J Neurol Sci 243(1–2):13–20. https://doi.org/10.1016/j.jns.2005.11.005 CrossRefPubMed
Chruzander C, Ytterberg C, Gottberg K, Einarsson U, Widen Holmqvist L, Johansson S (2014) A 10-year follow-up of a population-based study of people with multiple sclerosis in Stockholm, Sweden: changes in health-related quality of life and the value of different factors in predicting health-related quality of life. J Neurol Sci 339(1–2):57–63. https://doi.org/10.1016/j.jns.2014.01.020 CrossRefPubMed
Wynia K, van Wijlen AT, Middel B, Reijneveld SA, Meilof JF (2012) Change in disability profile and quality of life in multiple sclerosis patients: a five-year longitudinal study using the Multiple Sclerosis Impact Profile (MSIP). Mult Scler 18(5):654–661. https://doi.org/10.1177/1352458511423935 CrossRefPubMed
Ben Ari Shevil E, Johansson S, Ytterberg C, Bergstrom J, von Koch L (2014) How are cognitive impairment, fatigue and signs of depression related to participation in daily life among persons with multiple sclerosis? Disabil Rehabil 36(23):2012–2018. https://doi.org/10.3109/09638288.2014.887797 CrossRefPubMed
Signori A, Gallo F, Bovis F, Di Tullio N, Maietta I, Sormani MP (2016) Long-term impact of interferon or Glatiramer acetate in multiple sclerosis: a systematic review and meta-analysis. Mult Scler Relat Disord 6:57–63. https://doi.org/10.1016/j.msard.2016.01.007 CrossRefPubMed
Hobart J, Cano S, O’Connor R, Kinos S, Roullet E, Polman CH, Uitdehaag BM, McGuigan C, Hutchinson M, Durastanti V, Pozzilli C, Porcel J, Sastre-Garriga J, Montalban X, Mansson E, Lexell J, Thompson A (2003) Multiple Sclerosis Impact Scale-29 (MSIS-29): measurement stability across eight European countries. Paper presented at the European Committee for Treatment and Research in Multiple Sclerosis Congress, Milano
Motl RW, Cohen JA, Benedict R, Phillips G, LaRocca N, Hudson LD, Rudick R, Multiple Sclerosis Outcome Assessments C (2017) Validity of the timed 25-foot walk as an ambulatory performance outcome measure for multiple sclerosis. Mult Scler 23(5):704–710. https://doi.org/10.1177/1352458517690823 CrossRefPubMedPubMedCentral
Feys P, Lamers I, Francis G, Benedict R, Phillips G, LaRocca N, Hudson LD, Rudick R, Multiple Sclerosis Outcome Assessments C (2017) The Nine-Hole Peg Test as a manual dexterity performance measure for multiple sclerosis. Mult Scler 23(5):711–720. https://doi.org/10.1177/1352458517690824 CrossRefPubMedPubMedCentral
Benedict RH, DeLuca J, Phillips G, LaRocca N, Hudson LD, Rudick R, Multiple Sclerosis Outcome Assessments C (2017) Validity of the Symbol Digit Modalities Test as a cognition performance outcome measure for multiple sclerosis. Mult Scler 23(5):721–733. https://doi.org/10.1177/1352458517690821 CrossRefPubMedPubMedCentral
Learmonth YC, Dlugonski D, Pilutti LA, Sandroff BM, Klaren R, Motl RW (2013) Psychometric properties of the Fatigue Severity Scale and the Modified Fatigue Impact Scale. J Neurol Sci 331(1–2):102–107. https://doi.org/10.1016/j.jns.2013.05.023 CrossRefPubMed
Beck AT, Steer RA (1996) Beck Depression Inventory, Manual, Svensk version (Swedish version). In. Psykologiförlaget AB, Fagernes, Norway,
Asberg KH, Sonn U (1989) The cumulative structure of personal and instrumental ADL. A study of elderly people in a health service district. Scand J Rehabil Med 21(4):171–177 PubMed
Brorsson B, Asberg KH (1984) Katz index of independence in ADL. Reliability and validity in short-term care. Scand J Rehabil Med 16(3):125–132 PubMed
Smrtka J, Brown T, Bjorklund G (2016) Loss of mobility and the patient burden of multiple sclerosis: expert opinion on relevance to daily clinical practice. Postgrad Med 128(1):145–151. https://doi.org/10.1080/00325481.2016.1120162 CrossRefPubMed
Brissart H, Morele E, Baumann C, Perf ML, Leininger M, Taillemite L, Dillier C, Pittion S, Spitz E, Debouverie M (2013) Cognitive impairment among different clinical courses of multiple sclerosis. Neurol Res 35(8):867–872. https://doi.org/10.1179/1743132813Y.0000000232 CrossRefPubMed
Pearson M, Dieberg G, Smart N (2015) Exercise as a therapy for improvement of walking ability in adults with multiple sclerosis: a meta-analysis. Arch Phys Med Rehabil 96(7):1339 e1337–1348 e1337. https://doi.org/10.1016/j.apmr.2015.02.011 CrossRef
Thomas PW, Thomas S, Hillier C, Galvin K, Baker R (2006) Psychological interventions for multiple sclerosis. Cochrane Database Syst Rev 1:CD004431. https://doi.org/10.1002/14651858.CD004431.pub2
Schwartz CE, Andresen EM, Nosek MA, Krahn GL, Measurement REPoHS (2007) Response shift theory: important implications for measuring quality of life in people with disability. Arch Phys Med Rehabil 88(4):529–536. https://doi.org/10.1016/j.apmr.2006.12.032 CrossRefPubMed
- Changes in disability in people with multiple sclerosis: a 10-year prospective study
Lena von Koch
- Springer Berlin Heidelberg
Neu im Fachgebiet Neurologie
Meistgelesene Bücher in der Neurologie
Mail Icon II